DK3087177T3 - Antistofproduktion ex vivo - Google Patents

Antistofproduktion ex vivo Download PDF

Info

Publication number
DK3087177T3
DK3087177T3 DK14825470.9T DK14825470T DK3087177T3 DK 3087177 T3 DK3087177 T3 DK 3087177T3 DK 14825470 T DK14825470 T DK 14825470T DK 3087177 T3 DK3087177 T3 DK 3087177T3
Authority
DK
Denmark
Prior art keywords
vivo
antibody production
antibody
production
Prior art date
Application number
DK14825470.9T
Other languages
English (en)
Inventor
Helden Paula Maria Wilhelmina Van
Mark Jeroen Kwakkenbos
Hergen Spits
Tim Beaumont
Original Assignee
Kling Biotherapeutics B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kling Biotherapeutics B V filed Critical Kling Biotherapeutics B V
Application granted granted Critical
Publication of DK3087177T3 publication Critical patent/DK3087177T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0635B lymphocytes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018Orthomyxoviridae, e.g. influenza virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/04Immortalised cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13045Special targeting system for viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00Vectors comprising a targeting moiety
    • C12N2810/50Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/6045RNA rev transcr viruses
    • C12N2810/6054Retroviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK14825470.9T 2013-12-24 2014-12-24 Antistofproduktion ex vivo DK3087177T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13199584 2013-12-24
PCT/NL2014/050908 WO2015099534A1 (en) 2013-12-24 2014-12-24 Ex vivo antibody production

Publications (1)

Publication Number Publication Date
DK3087177T3 true DK3087177T3 (da) 2022-10-03

Family

ID=49885067

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14825470.9T DK3087177T3 (da) 2013-12-24 2014-12-24 Antistofproduktion ex vivo

Country Status (15)

Country Link
US (2) US20170009205A1 (da)
EP (2) EP3087177B1 (da)
JP (1) JP6832705B2 (da)
CN (1) CN106029873A (da)
AU (1) AU2014370516B9 (da)
BR (1) BR112016014881B1 (da)
CA (1) CA2934660C (da)
DK (1) DK3087177T3 (da)
EA (1) EA201691112A1 (da)
ES (1) ES2927905T3 (da)
HU (1) HUE060145T2 (da)
IL (1) IL246409B (da)
MX (1) MX2016008345A (da)
SG (1) SG11201605126YA (da)
WO (1) WO2015099534A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ611600A (en) * 2010-12-02 2015-02-27 Aimm Therapeutics Bv Means and methods for producing high affinity antibodies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2484166C (en) * 2002-04-26 2011-11-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Improved chimeric glycoproteins and pseudotyped lentiviral vectors
ATE474853T1 (de) * 2005-08-03 2010-08-15 Therapeutic Human Polyclonals Unterdrückung der b-zell apoptose in transgenen tieren die humanisierte immunglobulingene exprimieren
WO2007067046A1 (en) * 2005-12-09 2007-06-14 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of antibody producing cells
EP2400298B1 (en) * 2010-05-28 2013-08-14 F.Hoffmann-La Roche Ag Single B-cell cultivation method and specific antibody production
NZ611600A (en) * 2010-12-02 2015-02-27 Aimm Therapeutics Bv Means and methods for producing high affinity antibodies
MX2014005479A (es) * 2011-11-23 2014-08-18 Hoffmann La Roche Celulas de mamifero que expresan cd40l y su uso.
WO2014109696A1 (en) * 2013-01-10 2014-07-17 Alf Grandien Method for immortalization of b cells and uses thereof
BR112016017597A2 (pt) * 2014-01-31 2017-08-08 Aimm Therapeutics Bv Métodos para produzir uma célula b, para selecionar pelo menos uma célula b, para produzir anticorpos específicos para um antígeno de interesse e para identificar pelo menos uma mutação na sequência de aminoácido da cadeia pesada e/ou cadeia leve de um anticorpo

Also Published As

Publication number Publication date
EA201691112A1 (ru) 2017-01-30
NZ722156A (en) 2021-08-27
EP4141108A1 (en) 2023-03-01
HUE060145T2 (hu) 2023-02-28
US20200149007A1 (en) 2020-05-14
EP3087177A1 (en) 2016-11-02
AU2014370516B9 (en) 2021-07-29
BR112016014881B1 (pt) 2023-03-28
AU2014370516B2 (en) 2021-03-11
MX2016008345A (es) 2017-02-08
AU2014370516A1 (en) 2016-07-07
US20170009205A1 (en) 2017-01-12
SG11201605126YA (en) 2016-07-28
JP6832705B2 (ja) 2021-02-24
EP3087177B1 (en) 2022-09-14
IL246409A0 (en) 2016-08-31
WO2015099534A1 (en) 2015-07-02
CA2934660C (en) 2023-03-14
BR112016014881A8 (pt) 2020-06-09
CA2934660A1 (en) 2015-07-02
JP2017500052A (ja) 2017-01-05
BR112016014881A2 (pt) 2017-08-08
IL246409B (en) 2022-01-01
ES2927905T3 (es) 2022-11-11
CN106029873A (zh) 2016-10-12

Similar Documents

Publication Publication Date Title
DK3336106T3 (da) Anti-fcrh5-antistoffer
DK3342773T3 (da) Syk-hæmmere
DK3613453T3 (da) Fordamper
DK3708583T3 (da) Ikke-fucosylerede anti-fgfr2iiib-antistoffer
DOS2013000297S (es) Brazalete
DK3077047T3 (da) Aramcholsalte
DK3060460T3 (da) Saddel
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
DK3068800T3 (da) FcRn-specifikke antistoffer
DK2956698T3 (da) Bindestrimler
DK3052081T3 (da) Pastil
DK2946640T3 (da) Langmuir-probe
DK3065774T3 (da) Anti-CCL17-antistoffer
DK3071227T3 (da) Fiskevaccine
DE102013106534B8 (de) Chromatographiepipettenspitze
DE112014001252A5 (de) Aufbissschiene
DK2981168T3 (da) Laminitiskile
DK3087177T3 (da) Antistofproduktion ex vivo
DK3086679T3 (da) Sportssko
ES1078715Y (es) Mosquitera
DE112014005422A5 (de) Friktionsfalschdrallaggregat
BR112016000501A2 (pt) Nalador
CU20130009S4 (es) Adorno
DOS2013000134S (es) Pulsera
SM201300005S (it) Ciondoli